hotspot -WSS

hotspot

author：fashion 2025-09-29 09:29:42 - browse：22

Diversity in clinical trials concept — Adobe

The persistent lack of diversity among participants in clinical trials is a critical issue that is harming both populations that have long been left out of pivotal medical studies and the entire biomedical research enterprise, according to the authors of a report released Tuesday by the National Academies of Sciences, Engineering and Medicine.

Describing the need to move away from trials that focus largely on white men as “urgent,” the report’s authors called for a paradigm shift that gives less power to institutions that fund and conduct clinical research and more to communities under study. The sternly worded report said funding to include and recruit more diverse participants should be a priority that is enforced and said such investments could eventually lead to massive cost savings as the nation’s health disparities are reduced.

“An equitable clinical research enterprise would include trials and studies that match the demographics of the disease burden under study,” the report said. “However, we remain far from achieving this goal.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Immunocompromised patients offer clues on chronic Covid

WSS

HPV vaccine, cervical cancer study delivers historic results

Update the Apgar Score to remove skin color

Dog Aging Project founders on what lies ahead after losing funding

HPV vaccine, cervical cancer study delivers historic results

Care demand spikes challenge UnitedHealth’s provider arm

Cardiologists urge adding sexual orientation, gender identity to health records

knowledge

hotspot

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

The cancer drug shortage isn’t new — and neither are the solutions

Dana Farber says 6 studies to be retracted and 31 corrected

Heart attack and stroke risk calculators need revising

Flu vaccine reformulation won't be easy, manufacturers warn

DIEP, the 'gold standard' of breast reconstruction, is under threat

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Cancer drug shortages should be causing more outrage

Maisha Meds is a PBM, but don't call it that

focus

Head of FDA's diagnostics center, who led through Covid, retires

Future doctors need a strong humanities education

Dana Farber says 6 studies to be retracted and 31 corrected

Pumping milk in bathrooms at health conferences is common

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Does aspartame cause cancer? What new WHO guidance says

focus

entertainment

leisure time

entertainment